Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study
Craig Erker, Martin Mynarek, Simon Bailey, et al.
Neuro-Oncology
|
June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study
Katja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Nature Communications
|
September 27, 2019
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, et al.
Acta Neuropathologica
|
July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroup
Florence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
Rahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Cell Reports. Medicine
|
August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma
Liana Nobre, Michal Zapotocky, Sara Khan, et al.
Cell
|
December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2017
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Alvaro Lassaletta, Michal Zapotocky, Matthew Mistry, et al.
Cancer Discovery
|
October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R Fernandez, Adrian Levine, et al.
JCO Precision Oncology
|
September 14, 2020
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition
Liana Nobre, Michal Zapotocky, Vijay Ramaswamy, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study
Craig Erker, Martin Mynarek, Simon Bailey, et al.
Neuro-Oncology
|
June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study
Katja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Nature Communications
|
September 27, 2019
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, et al.
Acta Neuropathologica
|
July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroup
Florence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
Rahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Cell Reports. Medicine
|
August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma
Liana Nobre, Michal Zapotocky, Sara Khan, et al.
Cell
|
December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2017
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Alvaro Lassaletta, Michal Zapotocky, Matthew Mistry, et al.
Cancer Discovery
|
October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R Fernandez, Adrian Levine, et al.
JCO Precision Oncology
|
September 14, 2020
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition
Liana Nobre, Michal Zapotocky, Vijay Ramaswamy, et al.
Page
of 10